Suggested remit: To appraise the clinical and cost effectiveness of 3D collagen matrix (novocart 3D) within its marketing authorisation for treating articular cartilage defects of the knee.
Topic is suspended
- Status:
- Suspended
- Decision:
- Prioritised
- Process:
- TA
- ID number:
- 2707
Project Team
- Project lead
- Michelle Adhemar
Email enquiries
If you have any queries please email scopingta@nice.org.uk
Timeline
Key events during the development of the guidance:
| Date | Update |
|---|---|
| 01 February 2021 | Note added to the project documents |
| 25 January 2021 | Suspended. Topic is suspended |
| 25 January 2021 | Note added to the project documents |
| 15 June 2020 - 13 July 2020 | Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators |
For further information on our processes and methods, please see our CHTE processes and methods manual